1. The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas
   Nobuo Kondoh et al, 2022, Cancers CrossRef
2. Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide
   Emale El Darzi et al, 2017, International Journal of Immunopathology and Pharmacology CrossRef
3. A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis
   Peili Chen et al, 2016, PLOS ONE CrossRef
4. Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer
   Prakash Gangadaran et al, 2022, Biomedicines CrossRef
5. Targeting of IL-4 and IL-13 receptors for cancer therapy
   Akiko Suzuki et al, 2015, Cytokine CrossRef
6. Approaches for Head and Neck Cancer Research – Current Status and the Way Forward
   Barghavi V. et al, 2022, Cancer Investigation CrossRef
7. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer
   Minsu Kwon et al, 2015, European Journal of Cancer CrossRef
8. IL4 Receptor–Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity
   Sri Murugan Poongkavithai Vadevoo et al, 2017, Molecular Cancer Therapeutics CrossRef
9. A novel interleukin‐13 receptor alpha 2‐targeted hybrid peptide for effective glioblastoma therapy
   Ryohsuke Kurihara et al, 2019, Chemical Biology & Drug Design CrossRef
10. Assessment of Oxidative Stress-Induced Oral Epithelial Toxicity
    Ali I. Mohammed et al, 2023, Biomolecules CrossRef